Leandi van der Westhuizen, Jörn Weisner, Abu Taher, Ina Landel, Lena Quambusch, Marius Lindemann, Niklas Uhlenbrock, Matthias P Müller, Ivan R Green, Stephen C Pelly, Daniel Rauh, Willem A L van Otterlo
ChemMedChem 2022 May 18Akt is a protein kinase that has been implicated in the progression of cancerous tumours. A number of covalent allosteric Akt inhibitors are known, and based on these scaffolds, a small library of novel potential covalent allosteric imidazopyridine-based inhibitors was designed. The envisaged compounds were synthesised, with click chemistry enabling a modular approach to a number of the target compounds. The binding modes, potencies and antiproliferative activities of these synthesised compounds were explored, thereby furthering the structure activity relationship knowledge of this class of Akt inhibitors. Three novel covalent inhibitors were identified, exhibiting moderate activity against Akt1 and various cancer cell lines, potentially paving the way for future covalent allosteric inhibitors with improved properties. © 2022 The Authors. ChemMedChem published by Wiley-VCH GmbH.
Leandi van der Westhuizen, Jörn Weisner, Abu Taher, Ina Landel, Lena Quambusch, Marius Lindemann, Niklas Uhlenbrock, Matthias P Müller, Ivan R Green, Stephen C Pelly, Daniel Rauh, Willem A L van Otterlo. Covalent Allosteric Inhibitors of Akt Generated Using a Click Fragment Approach. ChemMedChem. 2022 May 18;17(10):e202100776
PMID: 35170857
View Full Text